Header Logo

RICHARD ERIC DAVIS

TitleAssociate Professor
InstitutionMD Anderson
DepartmentLymphoma-Myeloma
Address7455 Fannin St
Houston TX 77054-1901
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Davis RL, Taylor BC, Johnson N, Ferrel JR, Castaneda J. Retrograde Versus Antegrade Femoral Bone Graft Harvesting Using the Reamer-Irrigator-Aspirator. J Orthop Trauma. 2015 Aug; 29(8):370-2. PMID: 25635359.
      Citations: 2     Fields:    Translation:Humans
    2. Cho BS, Zeng Z, Mu H, Wang Z, Konoplev S, McQueen T, Protopopova M, Cortes J, Marszalek JR, Peng SB, Ma W, Davis RE, Thornton DE, Andreeff M, Konopleva M. Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy. Blood. 2015 Jul 09; 126(2):222-32. PMID: 26031918; PMCID: PMC4497963.
      Citations: 52     Fields:    Translation:HumansAnimalsCells
    3. Fowler NH, Davis RE, Rawal S, Nastoupil L, Hagemeister FB, McLaughlin P, Kwak LW, Romaguera JE, Fanale MA, Fayad LE, Westin JR, Shah J, Orlowski RZ, Wang M, Turturro F, Oki Y, Claret LC, Feng L, Baladandayuthapani V, Muzzafar T, Tsai KY, Samaniego F, Neelapu SS. Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial. Lancet Oncol. 2014 Nov; 15(12):1311-8. PMID: 25439689; PMCID: PMC4370362.
      Citations: 89     Fields:    Translation:HumansCTClinical Trials
    4. Li J, Kurasawa Y, Wang Y, Clise-Dwyer K, Klumpp SA, Liang H, Tailor RC, Raymond AC, Estrov Z, Brandt SJ, Davis RE, Zweidler-McKay P, Amin HM, Nagarajan L. Requirement for ssbp2 in hematopoietic stem cell maintenance and stress response. J Immunol. 2014 Nov 01; 193(9):4654-62. PMID: 25238756; PMCID: PMC4201964.
      Citations: 8     Fields:    Translation:AnimalsCells
    5. Voo KS, Foglietta M, Percivalle E, Chu F, Nattamai D, Harline M, Lee ST, Bover L, Lin HY, Baladandayuthapani V, Delgado D, Luong A, Davis RE, Kwak LW, Liu YJ, Neelapu SS. Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphoma. Int J Cancer. 2014 Dec 15; 135(12):2834-46. PMID: 24771328; PMCID: PMC4352105.
      Citations: 13     Fields:    Translation:HumansCells
    6. Jacamo R, Chen Y, Wang Z, Ma W, Zhang M, Spaeth EL, Wang Y, Battula VL, Mak PY, Schallmoser K, Ruvolo P, Schober WD, Shpall EJ, Nguyen MH, Strunk D, Bueso-Ramos CE, Konoplev S, Davis RE, Konopleva M, Andreeff M. Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-?B mediates chemoresistance. Blood. 2014 Apr 24; 123(17):2691-702. PMID: 24599548; PMCID: PMC3999754.
      Citations: 129     Fields:    Translation:HumansAnimalsCells
    7. Rawal S, Chu F, Zhang M, Park HJ, Nattamai D, Kannan S, Sharma R, Delgado D, Chou T, Lin HY, Baladandayuthapani V, Luong A, Vega F, Fowler N, Dong C, Davis RE, Neelapu SS. Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironment. J Immunol. 2013 Jun 15; 190(12):6681-93. PMID: 23686488; PMCID: PMC3680117.
      Citations: 38     Fields:    Translation:HumansCells
    8. Carter BZ, Mak DH, Wang Z, Ma W, Mak PY, Andreeff M, Davis RE. XIAP downregulation promotes caspase-dependent inhibition of proteasome activity in AML cells. Leuk Res. 2013 Aug; 37(8):974-9. PMID: 23669290; PMCID: PMC3700666.
      Citations: 6     Fields:    Translation:HumansCells
    9. Kojima K, Kornblau SM, Ruvolo V, Dilip A, Duvvuri S, Davis RE, Zhang M, Wang Z, Coombes KR, Zhang N, Qiu YH, Burks JK, Kantarjian H, Shacham S, Kauffman M, Andreeff M. Prognostic impact and targeting of CRM1 in acute myeloid leukemia. Blood. 2013 May 16; 121(20):4166-74. PMID: 23564911; PMCID: PMC3656451.
      Citations: 112     Fields:    Translation:HumansCells
    10. Fowler N, Davis E. Targeting B-cell receptor signaling: changing the paradigm. Hematology Am Soc Hematol Educ Program. 2013; 2013:553-60. PMID: 24319231.
      Citations: 22     Fields:    Translation:HumansCells
    11. Zheng Y, Yang J, Qian J, Qiu P, Hanabuchi S, Lu Y, Wang Z, Liu Z, Li H, He J, Lin P, Weber D, Davis RE, Kwak L, Cai Z, Yi Q. PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma. Leukemia. 2013 Mar; 27(3):702-10. PMID: 22996336; PMCID: PMC3652581.
      Citations: 71     Fields:    Translation:HumansAnimalsCells
    12. Kuhn DJ, Berkova Z, Jones RJ, Woessner R, Bjorklund CC, Ma W, Davis RE, Lin P, Wang H, Madden TL, Wei C, Baladandayuthapani V, Wang M, Thomas SK, Shah JJ, Weber DM, Orlowski RZ. Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma. Blood. 2012 Oct 18; 120(16):3260-70. PMID: 22932796; PMCID: PMC3476538.
      Citations: 88     Fields:    Translation:HumansAnimalsCells
    13. Gu Z, Zhang F, Wang ZQ, Ma W, Davis RE, Wang Z. The p44/wdr77-dependent cellular proliferation process during lung development is reactivated in lung cancer. Oncogene. 2013 Apr 11; 32(15):1888-900. PMID: 22665061; PMCID: PMC3935615.
      Citations: 18     Fields:    Translation:HumansAnimalsCells
    14. Lemoine M, Derenzini E, Buglio D, Medeiros LJ, Davis RE, Zhang J, Ji Y, Younes A. The pan-deacetylase inhibitor panobinostat induces cell death and synergizes with everolimus in Hodgkin lymphoma cell lines. Blood. 2012 Apr 26; 119(17):4017-25. PMID: 22408261; PMCID: PMC3350366.
      Citations: 38     Fields:    Translation:HumansCells
    15. O'Connor CM, Sheppard S, Hartline CA, Huls H, Johnson M, Palla SL, Maiti S, Ma W, Davis RE, Craig S, Lee DA, Champlin R, Wilson H, Cooper LJ. Adoptive T-cell therapy improves treatment of canine non-Hodgkin lymphoma post chemotherapy. Sci Rep. 2012; 2:249. PMID: 22355761; PMCID: PMC3278154.
      Citations: 33     Fields:    Translation:AnimalsCells
    16. Derenzini E, Lemoine M, Buglio D, Katayama H, Ji Y, Davis RE, Sen S, Younes A. The JAK inhibitor AZD1480 regulates proliferation and immunity in Hodgkin lymphoma. Blood Cancer J. 2011 Dec; 1(12):e46. PMID: 22829094; PMCID: PMC3255510.
      Citations: 34     Fields:    
    17. Davis RE, Westin JR. Vive la r?sistance: stem cells in mantle cell lymphoma. Leuk Lymphoma. 2011 Jun; 52(6):944-5. PMID: 21463111.
      Citations:    Fields:    Translation:HumansCells
    18. Bjorklund CC, Ma W, Wang ZQ, Davis RE, Kuhn DJ, Kornblau SM, Wang M, Shah JJ, Orlowski RZ. Evidence of a role for activation of Wnt/beta-catenin signaling in the resistance of plasma cells to lenalidomide. J Biol Chem. 2011 Apr 01; 286(13):11009-20. PMID: 21189262; PMCID: PMC3064156.
      Citations: 63     Fields:    Translation:HumansCells
    19. Annunziata CM, Hernandez L, Davis RE, Zingone A, Lamy L, Lam LT, Hurt EM, Shaffer AL, Kuehl WM, Staudt LM. A mechanistic rationale for MEK inhibitor therapy in myeloma based on blockade of MAF oncogene expression. Blood. 2011 Feb 24; 117(8):2396-404. PMID: 21163924; PMCID: PMC3062408.
      Citations: 35     Fields:    Translation:HumansCells
    20. Rui L, Emre NC, Kruhlak MJ, Chung HJ, Steidl C, Slack G, Wright GW, Lenz G, Ngo VN, Shaffer AL, Xu W, Zhao H, Yang Y, Lamy L, Davis RE, Xiao W, Powell J, Maloney D, Thomas CJ, Rosenwald A, Ott G, Muller-Hermelink HK, Savage K, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Weisenburger DD, Chan WC, Gascoyne RD, Levens D, Staudt LM, M?ller P. Cooperative epigenetic modulation by cancer amplicon genes. Cancer Cell. 2010 Dec 14; 18(6):590-605. PMID: 21156283; PMCID: PMC3049192.
      Citations: 125     Fields:    Translation:HumansCells
    21. Xia D, Davis RL, Crawford JA, Abraham JL. Gadolinium released from MR contrast agents is deposited in brain tumors: in situ demonstration using scanning electron microscopy with energy dispersive X-ray spectroscopy. Acta Radiol. 2010 Dec; 51(10):1126-36. PMID: 20868305.
      Citations: 24     Fields:    Translation:Humans
    22. Ma W, Wang M, Wang ZQ, Sun L, Graber D, Matthews J, Champlin R, Yi Q, Orlowski RZ, Kwak LW, Weber DM, Thomas SK, Shah J, Kornblau S, Davis RE. Effect of long-term storage in TRIzol on microarray-based gene expression profiling. Cancer Epidemiol Biomarkers Prev. 2010 Oct; 19(10):2445-52. PMID: 20805315; PMCID: PMC2966770.
      Citations: 26     Fields:    Translation:HumansCells
    23. Davis RE, Ngo VN, Lenz G, Tolar P, Young RM, Romesser PB, Kohlhammer H, Lamy L, Zhao H, Yang Y, Xu W, Shaffer AL, Wright G, Xiao W, Powell J, Jiang JK, Thomas CJ, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Johnson NA, Rimsza LM, Campo E, Jaffe ES, Wilson WH, Delabie J, Smeland EB, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Pierce SK, Staudt LM. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature. 2010 Jan 07; 463(7277):88-92. PMID: 20054396; PMCID: PMC2845535.
      Citations: 616     Fields:    Translation:HumansCells
    24. Coffey GP, Rajapaksa R, Liu R, Sharpe O, Kuo CC, Krauss SW, Sagi Y, Davis RE, Staudt LM, Sharman JP, Robinson WH, Levy S. Engagement of CD81 induces ezrin tyrosine phosphorylation and its cellular redistribution with filamentous actin. J Cell Sci. 2009 Sep 01; 122(Pt 17):3137-44. PMID: 19654214; PMCID: PMC2729262.
      Citations: 31     Fields:    Translation:HumansCells
    25. Meragelman TL, Scudiero DA, Davis RE, Staudt LM, McCloud TG, Cardellina JH, Shoemaker RH. Inhibitors of the NF-kappaB activation pathway from Cryptocarya rugulosa. J Nat Prod. 2009 Mar 27; 72(3):336-9. PMID: 19093800.
      Citations: 12     Fields:    Translation:HumansAnimalsCells
    26. Ngo VN, Lee J, Collins C, Zheng L, Wan F, Davis RE, Lenz G, Anderson DE, Arnoult D, Sakai K, Zhang J, Meng Z, Veenstra TD, Staudt LM, Lenardo MJ, Bid?re N, Vazquez A. Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival. Nature. 2009 Mar 05; 458(7234):92-6. PMID: 19118383; PMCID: PMC2688735.
      Citations: 73     Fields:    Translation:HumansCells
    27. Lam LT, Davis RE, Ngo VN, Lenz G, Wright G, Xu W, Zhao H, Yu X, Dang L, Staudt LM. Compensatory IKKalpha activation of classical NF-kappaB signaling during IKKbeta inhibition identified by an RNA interference sensitization screen. Proc Natl Acad Sci U S A. 2008 Dec 30; 105(52):20798-803. PMID: 19104039; PMCID: PMC2634958.
      Citations: 50     Fields:    Translation:HumansCells
    28. Davis RE. In vitro chemosensitivity testing in the genomic era. Leuk Lymphoma. 2008 Nov; 49(11):2040-1. PMID: 19021046.
      Citations:    Fields:    Translation:HumansCells
    29. Lenz G, Wright GW, Emre NC, Kohlhammer H, Dave SS, Davis RE, Carty S, Lam LT, Shaffer AL, Xiao W, Powell J, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Campo E, Jaffe ES, Delabie J, Smeland EB, Rimsza LM, Fisher RI, Weisenburger DD, Chan WC, Staudt LM. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci U S A. 2008 Sep 09; 105(36):13520-5. PMID: 18765795; PMCID: PMC2533222.
      Citations: 400     Fields:    Translation:Humans
    30. Lenz G, Davis RE, Ngo VN, Lam L, George TC, Wright GW, Dave SS, Zhao H, Xu W, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Fisher RI, Chan WC, Staudt LM. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science. 2008 Mar 21; 319(5870):1676-9. PMID: 18323416.
      Citations: 391     Fields:    Translation:HumansCells
    31. Lam LT, Wright G, Davis RE, Lenz G, Farinha P, Dang L, Chan JW, Rosenwald A, Gascoyne RD, Staudt LM. Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma. Blood. 2008 Apr 01; 111(7):3701-13. PMID: 18160665; PMCID: PMC2275028.
      Citations: 172     Fields:    Translation:HumansCells
    32. Xie Y, Deng S, Thomas CJ, Liu Y, Zhang YQ, Rinderspacher A, Huang W, Gong G, Wyler M, Cayanis E, Aulner N, Chung C, Pampou S, Southall N, Vidovic D, Branden L, Davis RE, Staudt LM, Inglese J, Austin CP, Landry DW, Smith DH, Auld DS, T?bben U, Sch?rer S. Identification of N-(quinolin-8-yl)benzenesulfonamides as agents capable of down-regulating NFkappaB activity within two separate high-throughput screens of NFkappaB activation. Bioorg Med Chem Lett. 2008 Jan 01; 18(1):329-35. PMID: 18024113; PMCID: PMC2275118.
      Citations: 3     Fields:    Translation:Cells
    33. Annunziata CM, Davis RE, Demchenko Y, Bellamy W, Gabrea A, Zhan F, Lenz G, Hanamura I, Wright G, Xiao W, Dave S, Hurt EM, Tan B, Zhao H, Stephens O, Santra M, Williams DR, Dang L, Barlogie B, Shaughnessy JD, Kuehl WM, Staudt LM. Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell. 2007 Aug; 12(2):115-30. PMID: 17692804; PMCID: PMC2730509.
      Citations: 458     Fields:    Translation:HumansCells
    34. Davis RE, Zhang YQ, Southall N, Staudt LM, Austin CP, Inglese J, Auld DS. A cell-based assay for IkappaBalpha stabilization using a two-color dual luciferase-based sensor. Assay Drug Dev Technol. 2007 Feb; 5(1):85-103. PMID: 17355202.
      Citations: 9     Fields:    Translation:HumansCells
    35. Dunleavy K, Davis RE, Landgren O, Staudt LM, Wilson WH. BCL-6 and rituximab in diffuse large B-cell lymphoma: where are we? Blood. 2007 Jan 15; 109(2):843-4; discussion 844-5. PMID: 17210865.
      Citations: 2     Fields:    Translation:Humans
    36. Shaffer AL, Wright G, Yang L, Powell J, Ngo V, Lamy L, Lam LT, Davis RE, Staudt LM. A library of gene expression signatures to illuminate normal and pathological lymphoid biology. Immunol Rev. 2006 Apr; 210:67-85. PMID: 16623765.
      Citations: 111     Fields:    Translation:Humans
    37. Ngo VN, Davis RE, Lamy L, Yu X, Zhao H, Lenz G, Lam LT, Dave S, Yang L, Powell J, Staudt LM. A loss-of-function RNA interference screen for molecular targets in cancer. Nature. 2006 May 04; 441(7089):106-10. PMID: 16572121.
      Citations: 282     Fields:    Translation:HumansCells
    38. Zhang Y, James M, Middleton FA, Davis RL. Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms. Am J Med Genet B Neuropsychiatr Genet. 2005 Aug 05; 137B(1):5-16. PMID: 15965975.
      Citations: 116     Fields:    Translation:HumansCells
    39. Song L, Zlobin A, Ghoshal P, Zhang Q, Houde C, Weijzen S, Jiang Q, Nacheva E, Yagan D, Davis E, Galiegue-Zouitina S, Catovsky D, Grogan T, Fisher RI, Miele L, Coignet LJ. Alteration of SMRT tumor suppressor function in transformed non-Hodgkin lymphomas. Cancer Res. 2005 Jun 01; 65(11):4554-61. PMID: 15930272.
      Citations: 8     Fields:    Translation:HumansCells
    40. Lam LT, Davis RE, Pierce J, Hepperle M, Xu Y, Hottelet M, Nong Y, Wen D, Adams J, Dang L, Staudt LM. Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling. Clin Cancer Res. 2005 Jan 01; 11(1):28-40. PMID: 15671525.
      Citations: 144     Fields:    Translation:HumansCells
    41. Ho L, Davis RE, Chappuis R, Berczy M, Mhawech P, Staudt LM, Schwaller J, Conne B. MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells. Blood. 2005 Apr 01; 105(7):2891-9. PMID: 15598810.
      Citations: 19     Fields:    Translation:HumansCells
    42. Crowder C, Davis RE, Gabrielsen OS, Rudikoff S, Dahle ?. PML mediates IFN-alpha-induced apoptosis in myeloma by regulating TRAIL induction. Blood. 2005 Feb 01; 105(3):1280-7. PMID: 15459016.
      Citations: 15     Fields:    Translation:HumansCells
    43. Rosenwald A, Chuang EY, Davis RE, Wiestner A, Alizadeh AA, Arthur DC, Mitchell JB, Marti GE, Fowler DH, Wilson WH, Staudt LM. Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response. Blood. 2004 Sep 01; 104(5):1428-34. PMID: 15138159.
      Citations: 36     Fields:    Translation:HumansCellsCTClinical Trials
    44. Wang Z, Dooley TP, Curto EV, Davis RL, VandeBerg JL. Cross-species application of cDNA microarrays to profile gene expression using UV-induced melanoma in Monodelphis domestica as the model system. Genomics. 2004 Apr; 83(4):588-99. PMID: 15028282.
      Citations: 10     Fields:    Translation:HumansAnimalsCells
    45. Dooley TP, Curto EV, Reddy SP, Davis RL, Lambert GW, Wilborn TW, Elson CO. Regulation of gene expression in inflammatory bowel disease and correlation with IBD drugs: screening by DNA microarrays. Inflamm Bowel Dis. 2004 Jan; 10(1):1-14. PMID: 15058520.
      Citations: 37     Fields:    Translation:HumansCells
    46. Meffre E, Schaefer A, Wardemann H, Wilson P, Davis E, Nussenzweig MC. Surrogate light chain expressing human peripheral B cells produce self-reactive antibodies. J Exp Med. 2004 Jan 05; 199(1):145-50. PMID: 14699083; PMCID: PMC1887722.
      Citations: 64     Fields:    Translation:HumansCells
    47. Fouladi M, Hunt DL, Pollack IF, Dueckers G, Burger PC, Becker LE, Yates AJ, Gilles FH, Davis RL, Boyett JM, Finlay JL. Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high-grade glioma study CCG-945. Cancer. 2003 Sep 15; 98(6):1243-52. PMID: 12973849.
      Citations: 40     Fields:    Translation:HumansCTClinical Trials
    48. Dooley TP, Reddy SP, Wilborn TW, Davis RL. Biomarkers of human cutaneous squamous cell carcinoma from tissues and cell lines identified by DNA microarrays and qRT-PCR. Biochem Biophys Res Commun. 2003 Jul 11; 306(4):1026-36. PMID: 12821146.
      Citations: 26     Fields:    Translation:HumansCells
    49. Dooley TP, Curto EV, Davis RL, Grammatico P, Robinson ES, Wilborn TW. DNA microarrays and likelihood ratio bioinformatic methods: discovery of human melanocyte biomarkers. Pigment Cell Res. 2003 Jun; 16(3):245-53. PMID: 12753397.
      Citations: 8     Fields:    Translation:HumansCells
    50. Dooley TP, Curto EV, Reddy SP, Davis RL, Lambert G, Wilborn TW. A method to improve selection of molecular targets by circumventing the ADME pharmacokinetic system utilizing PharmArray DNA microarrays. Biochem Biophys Res Commun. 2003 Apr 11; 303(3):828-41. PMID: 12670486.
      Citations:    Fields:    Translation:HumansCells
    51. Wiestner A, Rosenwald A, Barry TS, Wright G, Davis RE, Henrickson SE, Zhao H, Ibbotson RE, Orchard JA, Davis Z, Stetler-Stevenson M, Raffeld M, Arthur DC, Marti GE, Wilson WH, Hamblin TJ, Oscier DG, Staudt LM. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood. 2003 Jun 15; 101(12):4944-51. PMID: 12595313.
      Citations: 168     Fields:    Translation:HumansCells
    52. Queiroz DM, Camargo AA, Simpson AJ, Magalh?es PP. CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma. Carcinogenesis. 2003 Jan; 24(1):145; author reply 147. PMID: 12538360.
      Citations: 2     Fields:    Translation:HumansCells
    53. Kalaitzidis D, Davis RE, Rosenwald A, Staudt LM, Gilmore TD. The human B-cell lymphoma cell line RC-K8 has multiple genetic alterations that dysregulate the Rel/NF-kappaB signal transduction pathway. Oncogene. 2002 Dec 12; 21(57):8759-68. PMID: 12483529.
      Citations: 26     Fields:    Translation:HumansCells
    54. Gilles FH, Leviton A, Adelman L, Rorke LB, Sobel EL, Hedley-Whyte ET, Davis RL, Tavar? CJ. Clinical and survival covariates of eight classes of childhood supratentorial neuroglial tumors. Cancer. 2002 Sep 15; 95(6):1302-10. PMID: 12216099.
      Citations: 1     Fields:    Translation:Humans
    55. Davis RE, Staudt LM. Molecular diagnosis of lymphoid malignancies by gene expression profiling. Curr Opin Hematol. 2002 Jul; 9(4):333-8. PMID: 12042708.
      Citations: 13     Fields:    Translation:Humans
    56. Curto EV, Lambert GW, Davis RL, Wilborn TW, Dooley TP. Biomarkers of human skin cells identified using DermArray DNA arrays and new bioinformatics methods. Biochem Biophys Res Commun. 2002 Mar 08; 291(4):1052-64. PMID: 11866472.
      Citations: 10     Fields:    Translation:HumansCells
    57. Shibata A, Parsonnet J, Longacre TA, Garcia MI, Puligandla B, Davis RE, Vogelman JH, Orentreich N, Habel LA. CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma. Carcinogenesis. 2002 Mar; 23(3):419-24. PMID: 11895856.
      Citations: 26     Fields:    Translation:HumansCells
    58. Davis RE, Brown KD, Siebenlist U, Staudt LM. Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med. 2001 Dec 17; 194(12):1861-74. PMID: 11748286; PMCID: PMC2193582.
      Citations: 405     Fields:    Translation:HumansCells
    59. Rosenwald A, Alizadeh AA, Widhopf G, Simon R, Davis RE, Yu X, Yang L, Pickeral OK, Rassenti LZ, Powell J, Botstein D, Byrd JC, Grever MR, Cheson BD, Chiorazzi N, Wilson WH, Kipps TJ, Brown PO, Staudt LM. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med. 2001 Dec 03; 194(11):1639-47. PMID: 11733578; PMCID: PMC2193523.
      Citations: 272     Fields:    Translation:Humans
    60. Lam LT, Pickeral OK, Peng AC, Rosenwald A, Hurt EM, Giltnane JM, Averett LM, Zhao H, Davis RE, Sathyamoorthy M, Wahl LM, Harris ED, Mikovits JA, Monks AP, Hollingshead MG, Sausville EA, Staudt LM. Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol. Genome Biol. 2001; 2(10):RESEARCH0041. PMID: 11597333; PMCID: PMC57796.
      Citations: 161     Fields:    Translation:HumansCells
    61. Meffre E, Davis E, Schiff C, Cunningham-Rundles C, Ivashkiv LB, Staudt LM, Young JW, Nussenzweig MC. Circulating human B cells that express surrogate light chains and edited receptors. Nat Immunol. 2000 Sep; 1(3):207-13. PMID: 10973277.
      Citations: 37     Fields:    Translation:HumansCells
    62. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever MR, Byrd JC, Botstein D, Brown PO, Staudt LM. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000 Feb 03; 403(6769):503-11. PMID: 10676951.
      Citations: 2579     Fields:    Translation:HumansCells
    63. Advani R, Saba HI, Tallman MS, Rowe JM, Wiernik PH, Ramek J, Dugan K, Lum B, Villena J, Davis E, Paietta E, Litchman M, Sikic BI, Greenberg PL. Treatment of refractory and relapsed acute myelogenous leukemia with combination chemotherapy plus the multidrug resistance modulator PSC 833 (Valspodar). Blood. 1999 Feb 01; 93(3):787-95. PMID: 9920827.
      Citations: 22     Fields:    Translation:HumansCTClinical Trials
    64. Blankenberg FG, Katsikis PD, Tait JF, Davis RE, Naumovski L, Ohtsuki K, Kopiwoda S, Abrams MJ, Strauss HW. Imaging of apoptosis (programmed cell death) with 99mTc annexin V. J Nucl Med. 1999 Jan; 40(1):184-91. PMID: 9935075.
      Citations: 44     Fields:    Translation:HumansAnimalsCells
    65. Advani R, Visani G, Milligan D, Saba H, Tallman M, Rowe JM, Wiernik PH, Ramek J, Dugan K, Lum B, Villena J, Davis E, Paietta E, Litchman M, Covelli A, Sikic B, Greenberg P. Treatment of poor prognosis AML patients using PSC833 (valspodar) plus mitoxantrone, etoposide, and cytarabine (PSC-MEC). Adv Exp Med Biol. 1999; 457:47-56. PMID: 10500779.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    66. Alizadeh A, Eisen M, Davis RE, Ma C, Sabet H, Tran T, Powell JI, Yang L, Marti GE, Moore DT, Hudson JR, Chan WC, Greiner T, Weisenburger D, Armitage JO, Lossos I, Levy R, Botstein D, Brown PO, Staudt LM. The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. Cold Spring Harb Symp Quant Biol. 1999; 64:71-8. PMID: 11232339.
      Citations: 62     Fields:    Translation:HumansCells
    67. Davis RE, Mysore V, Browning JC, Hsieh JC, Lu QA, Katsikis PD. In situ staining for poly(ADP-ribose) polymerase activity using an NAD analogue. J Histochem Cytochem. 1998 Nov; 46(11):1279-89. PMID: 9774627.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    68. Davis RE, Greenberg PL. Bcl-2 expression by myeloid precursors in myelodysplastic syndromes: relation to disease progression. Leuk Res. 1998 Sep; 22(9):767-77. PMID: 9716007.
      Citations: 8     Fields:    Translation:HumansCells
    69. Blankenberg FG, Katsikis PD, Tait JF, Davis RE, Naumovski L, Ohtsuki K, Kopiwoda S, Abrams MJ, Darkes M, Robbins RC, Maecker HT, Strauss HW. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci U S A. 1998 May 26; 95(11):6349-54. PMID: 9600968; PMCID: PMC27696.
      Citations: 127     Fields:    Translation:HumansAnimals
    70. Hausdorff J, Davis E, Long G, Hoppe R, van der Pas M, Lassman C, Kamel O, Jacobs C. Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy. Cancer J Sci Am. 1997 Sep-Oct; 3(5):303-11. PMID: 9327155.
      Citations: 3     Fields:    Translation:Humans
    71. Davis RE, Stenberg PE, Levin J, Beckstead JH. Localization of megakaryocytes in normal mice and following administration of platelet antiserum, 5-fluorouracil, or radiostrontium: evidence for the site of platelet production. Exp Hematol. 1997 Jul; 25(7):638-48. PMID: 9216740.
      Citations: 15     Fields:    Translation:AnimalsCells
    72. Soslow RA, Davis RE, Warnke RA, Cleary ML, Kamel OW. True histiocytic lymphoma following therapy for lymphoblastic neoplasms. Blood. 1996 Jun 15; 87(12):5207-12. PMID: 8652834.
      Citations: 5     Fields:    Translation:HumansCells
    73. Arber DA, Kamel OW, van de Rijn M, Davis RE, Medeiros LJ, Jaffe ES, Weiss LM. Frequent presence of the Epstein-Barr virus in inflammatory pseudotumor. Hum Pathol. 1995 Oct; 26(10):1093-8. PMID: 7557942.
      Citations: 73     Fields:    Translation:HumansCells
    74. Davis RE, Longacre TA, Cornbleet PJ. Hematogones in the bone marrow of adults. Immunophenotypic features, clinical settings, and differential diagnosis. Am J Clin Pathol. 1994 Aug; 102(2):202-11. PMID: 8042590.
      Citations: 4     Fields:    Translation:HumansCells
    75. Davis RE, Smoller BR. T lymphocytes expressing HECA-452 epitope are present in cutaneous acute graft-versus-host disease and erythema multiforme, but not in acute graft-versus-host disease in gut organs. Am J Pathol. 1992 Sep; 141(3):691-8. PMID: 1381561; PMCID: PMC1886711.
      Citations: 3     Fields:    Translation:HumansCells
    76. Davis RE, Warnke RA, Dorfman RF. Inflammatory pseudotumor of lymph nodes. Additional observations and evidence for an inflammatory etiology. Am J Surg Pathol. 1991 Aug; 15(8):744-56. PMID: 2069212.
      Citations: 7     Fields:    Translation:Humans
    77. Davis RE, Warnke RA, Dorfman RF, Cleary ML. Utility of molecular genetic analysis for the diagnosis of neoplasia in morphologically and immunophenotypically equivocal hematolymphoid lesions. Cancer. 1991 Jun 01; 67(11):2890-9. PMID: 2025855.
      Citations:    Fields:    Translation:Humans
    78. Kamel OW, LeBrun DP, Davis RE, Berry GJ, Warnke RA. Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/Cyclin 19A2. Correlation with Ki-67 labeling. Am J Pathol. 1991 Jun; 138(6):1471-7. PMID: 1675840; PMCID: PMC1886388.
      Citations: 31     Fields:    Translation:Humans
    79. Kemper CA, Davis RE, Deresinski SC, Dorfmann RF. Inflammatory pseudotumor of intra-abdominal lymph nodes manifesting as recurrent fever of unknown origin: a case report. Am J Med. 1991 Apr; 90(4):519-23. PMID: 2012094.
      Citations: 4     Fields:    Translation:Humans
    80. Davis RE, Dorfman RF, Warnke RA. Primary large-cell lymphoma of the thymus: a diffuse B-cell neoplasm presenting as primary mediastinal lymphoma. Hum Pathol. 1990 Dec; 21(12):1262-8. PMID: 2249839.
      Citations: 2     Fields:    Translation:Humans
    81. ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies. Science Signaling. 9.
    82. Errata. Blood. 126:1049.
    83. The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma. British Journal of Haematology.
    84. Thymidine phosphorylase exerts complex effects on bone resorption and formation in myeloma. Science Translational Medicine. 8.
    85. Inhibiting glutaminase in acute myeloid leukemia. Oncotarget. 7:79722-79735.
    86. Combination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cells. Biochimica et Biophysica Acta - Molecular Cell Research. 1863:562-571.
    87. Phase II clinical trail of patients with relapsed follicular lymphoma treated with a humanized antiprogrammed death-1 monoclonal antibody combined with rituximabrreport in the 54th ASH annual meeting. Journal of Leukemia and Lymphoma. 22:77-80.
    88. Tight Junction Protein 1 Modulates Proteasome Capacity and Proteasome Inhibitor Sensitivity in Multiple Myeloma via EGFR/JAK1/STAT3 Signaling. Cancer Cell.
    89. Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma. The Lancet Oncology. 15:69-77.
    90. Factors influencing outcome in advanced stage, low-grade follicular lymphoma treated at MD Anderson Cancer Center in the rituximab era. Annals of Oncology. 27:895-901.
    91. Inflammatory pseudotumor of intra-abdominal lymph nodes manifesting as recurrent fever of unknown origin. The American Journal of Medicine. 90:519-523.
    92. Hypoxia-activated prodrug TH-302 targets hypoxic bone marrow niches in preclinical leukemia models. Clinical Cancer Research. 22:1687-1698.
    93. Analysis of immune signatures in longitudinal tumor samples yields insight into biomarkers of response and mechanisms of resistance to immune checkpoint blockade. Cancer Discovery. 6:827-837.
    94. Effects of pharmacological and genetic disruption of CXCR4 chemokine receptor function in B-cell acute lymphoblastic leukaemia. British Journal of Haematology.
    95. Ribosomal biogenesis and translational flux inhibition by the selective inhibitor of nuclear export (sine) XPO1 antagonist KPT-185. PLoS One. 10.
    96. Erratum. Blood Cancer Journal. 4.
    97. Differential T-cell subset representation in cutaneous squamous cell carcinoma arising in immunosuppressed versus immunocompetent individuals. Experimental Dermatology. 25:245-247.
    98. Pre-BCR signaling in precursor B-cell acute lymphoblastic leukemia regulates PI3K/AKT, FOXO1 and MYC, and can be targeted by SYK inhibition. Leukemia.
    99. CCL3 and CCL4 are biomarkers for B cell receptor pathway activation and prognostic serum markers in diffuse large B cell lymphoma. British Journal of Haematology. 171:726-735.
    DAVIS's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (555)
    Explore
    _
    Co-Authors (44)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _